Evidence item

The 88% figure is the highest age-specific adjusted effectiveness estimate, with a 53–97 confidence interval, among completed three-dose cases aged 3–5 months. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 25977

Source: Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India · locator {} · excerpt hash sha256:62d437231e05d15f8fceea8105564a4a40cd902615a434bd1eb49d13e4461e45

Among 2,243 children aged 3–23 months hospitalized with acute gastroenteritis, 638 were ELISA-positive. For completed series (three doses), the aVE against hospitalization due to RVGE among children aged 3–23 months was 52% (95% CI, 32–66), with the highest aVE of 88% (CI, 53–97) observed among those aged 3–5 months.